MedPath
HSA Approval

RIFAREN 300 CAPSULE 300 mg

SIN10052P

RIFAREN 300 CAPSULE 300 mg

RIFAREN 300 CAPSULE 300 mg

September 13, 1998

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J04AB02

rifampicin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

RIFAMPICIN

300 mg

Rifampicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RIFAREN 300 CAPSULE 300 mg - HSA Approval | MedPath